This toolkit for the detection, management and control of carbapenemase-producing Enterobacteriaceae provides practical advice for clinicians, and staff at the frontline in an acute care setting. Further resources are available here. The non-acute toolkit is available here.  Published 2013 by Public Health England

AMRHAI (antimicrobial resistance and healthcare associated infections) is the national reference unit for investigating AMR in healthcare-associated bacteria.

In 2013, CDC published a comprehensive analysis outlining the top 18 antibiotic-resistant threats in the U.S., titled Antibiotic Resistance Threats in the United States, 2013 (AR Threats Report). The report ranked the 18 threats (bacteria and fungi) into three categories based on level of concern to human health—urgent, serious, and concerning. CDC is working towards releasing an updated AR Threats Report in fall 2019.

These guidelines provide recommendations that outline the critical aspects of infection prevention and control. The recommendations were developed using the best available evidence and consensus methods by the Infection Control Steering Committee. They have been prioritised as key areas to prevent and control infection in a healthcare facility. It is recognised that the level of risk may differ according to the different types of facility and therefore some recommendations should be justified by risk assessment.

This guideline covers preventing infective endocarditis (IE) in children, young people and adults. It focuses on people at increased risk of infective endocarditis undergoing dental, gastrointestinal tract, genitourinary and respiratory tract procedures. Published 2008, updated 2016.  Guidance to facilitate implementation developed by NHS Education for Scotland is available here

This is a revised edition of the “Guidance on Prevention and Control of Clostridium difficile Infection (CDI) in Health and Social Care Settings in Scotland” providing easily accessible advice covering key aspects of prevention and control of CDI.  Individual treatment algorithms for CDI are also provided.  First Episode  First recurrence   Second and subsequent recurrence